Asia-Pacific Infectious Diagnostics Market Outlook to 2021

1
Asia-Pacific Infectious Diagnostics Market
Outlook to 2021
2
Report Description
Summary Asia-Pacific Infectious Diagnostics
Market Outlook to 2021, provides key market data
on the Asia-Pacific Infectious Diagnostics
market. The report provides value, in millions of
US dollars within market segments - Hepatitis
Viruses, Retroviruses, Infectious Diagnostics
Multiple Parameters Panels, Bacteriology, Nucleic
Acid Testing Instruments, Other Virology,
Infectious Diagnostics Rapid Tests POC and
Parasitology Mycology. The report also
provides company shares and distribution shares
data for the market category, and global
corporate-level profiles of the key market
participants. Based on the availability of data
for the particular category and country,
information related to pipeline products, news
and deals is available in the report. Extensive
interviews are conducted with industry experts to
validate the market size, company share and
distribution share data and analysis. Get
complete Report _at_ http//www.bigmarketresearch.co
m/asia-pacific-infectious-diagnostics-outlook-to-2
021-market
3
Report Description
Scope - Infectious Diagnostics market includes
Hepatitis Viruses, Retroviruses, Infectious
Diagnostics Multiple Parameters Panels,
Bacteriology, Nucleic Acid Testing Instruments,
Other Virology, Infectious Diagnostics Rapid
Tests POC and Parasitology Mycology. -
Annualized market revenues (USD million) data for
each of the market categories. Data is provided
from 2007 to 2014 and forecast to 2021. - 2014
company shares and distribution shares data for
Infectious Diagnostics market. - Global
corporate-level profiles of key companies
operating within the Asia-Pacific Infectious
Diagnostics market. - Key players covered include
Siemens Healthcare, F. Hoffmann-La Roche Ltd.,
Abbott Laboratories, Hologic, Inc., Qiagen N.V.,
Becton, Dickinson and Company, Danaher
Corporation and Alere Inc.. Enquire About this
report _at_ http//www.bigmarketresearch.com/report-e
nquiry/377981
4
Report Description
Reasons to buy - Develop business strategies by
identifying the key market segments poised for
strong growth in the future. - Develop
market-entry and market expansion strategies. -
Design competition strategies by identifying
who-stands-where in the market. - Develop
investment strategies by identifying the key
market segments expected to register strong
growth in the near future. - What are the key
distribution channels and whats the most
preferred mode of product distribution -
Identify, understand and capitalize.
5
Table of Contents
Table Of Contents 1 Table of Contents 2 2
Introduction 7 2.1 What Is This Report About?
7 2.2 Infectious Diagnostics Market Segmentation
7 2.3 Definitions of Markets Covered in the
Report 8 3 Infectious Diagnostics Market,
Asia-Pacific 10 3.1 Infectious Diagnostics
Market, Asia-Pacific, Revenue (m), 2007-2021
10 3.2 Infectious Diagnostics Market,
Asia-Pacific, Category Comparison by Revenue
(m), 2007-2021 12 3.3 Infectious Diagnostics
Market, Asia-Pacific, Revenue (m), 2007-2014
14 3.4 Infectious Diagnostics Market,
Asia-Pacific, Revenue (m), 2014-2021 16 3.5
Infectious Diagnostics Market, Asia-Pacific,
Company Share by Revenue (m), 2014 18 4
Infectious Diagnostics Market, Australia 20 4.1
Infectious Diagnostics Market, Australia, Revenue
(m), 2007-2014 20 4.2 Infectious Diagnostics
Market, Australia, Revenue (m), 2014-2021 22 4.3
Infectious Diagnostics Market, Australia,
Distribution Share by Revenue (m), 2013-2014 4.4
Infectious Diagnostics Market, Australia, Company
Share by Revenue (m), 2014 29
6
Table of Contents
5 Infectious Diagnostics Market, China 31 5.1
Infectious Diagnostics Market, China, Revenue
(m), 2007-2014 31 5.2 Infectious Diagnostics
Market, China, Revenue (m), 2014-2021 33 5.3
Infectious Diagnostics Market, China,
Distribution Share by Revenue (m), 2013-2014
39 5.4 Infectious Diagnostics Market, China,
Company Share by Revenue (m), 2014 40 6
Infectious Diagnostics Market, India 42 6.1
Infectious Diagnostics Market, India, Revenue
(m), 2007-2014 42 6.2 Infectious Diagnostics
Market, India, Revenue (m), 2014-2021 44 6.3
Infectious Diagnostics Market, India,
Distribution Share by Revenue (m), 2013-2014
50 6.4 Infectious Diagnostics Market, India,
Company Share by Revenue (m), 2014 51 7
Infectious Diagnostics Market, Japan 53 7.1
Infectious Diagnostics Market, Japan, Revenue
(m), 2007-2014 53 7.2 Infectious Diagnostics
Market, Japan, Revenue (m), 2014-2021 55 7.3
Infectious Diagnostics Market, Japan,
Distribution Share by Revenue (m), 2013-2014
61 7.4 Infectious Diagnostics Market, Japan,
Company Share by Revenue (m), 2014 62
7
Table of Contents
8 Infectious Diagnostics Market, South Korea
64 8.1 Infectious Diagnostics Market, South
Korea, Revenue (m), 2007-2014 64 8.2 Infectious
Diagnostics Market, South Korea, Revenue (m),
2014-2021 66 8.3 Infectious Diagnostics Market,
South Korea, Distribution Share by Revenue (m),
2013-2014 72 8.4 Infectious Diagnostics Market,
South Korea, Company Share by Revenue (m), 2014
73 9 Overview of Key Companies in Asia-Pacific
Infectious Diagnostics Market 75 9.1 Abbott
Laboratories 75 9.2 F. Hoffmann-La Roche Ltd.
75 9.3 Siemens Healthcare 75 9.4 Danaher
Corporation 76 9.5 Transasia Bio-Medicals Ltd.
76 9.6 Qiagen N.V. 76 9.7 Bio-Rad Laboratories,
Inc. 77 9.8 Alere Inc. 77 9.9 Becton, Dickinson
and Company 77 9.10 bioMerieux S.A. 78 9.11
Hologic, Inc. 78 9.12 DiaSorin S.p.A 78
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/asia-pacific-infe
ctious-diagnostics-outlook-to-2021-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States